Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Oncolytics Biotech, Inc (NASDAQ: ONCY) closed at $0.97 in the last session, up 1.68% from day before closing price of $0.95. In other words, the price has increased by $1.68 from its previous closing price. On the day, 0.15 million shares were traded. ONCY stock price reached its highest trading level at $0.9999 during the session, while it also had its lowest trading level at $0.97.
Ratios:
We take a closer look at ONCY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 7.50 whereas as Long-Term Debt/Eq ratio is at 5.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on August 13, 2025, initiated with a Buy rating and assigned the stock a target price of $7.
On October 06, 2022, Maxim Group started tracking the stock assigning a Buy rating and target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on February 17, 2021, with a $15 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 104378184 and an Enterprise Value of 91444992.
Stock Price History:
The Beta on a monthly basis for ONCY is 0.96, which has changed by -0.050000012 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.51, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -7.63%, while the 200-Day Moving Average is calculated to be 8.57%.
Shares Statistics:
According to the various share statistics, ONCY traded on average about 836.91K shares per day over the past 3-months and 560060 shares per day over the past 10 days. A total of 103.64M shares are outstanding, with a floating share count of 98.71M. Insiders hold about 1.64% of the company’s shares, while institutions hold 2.81% stake in the company. Shares short for ONCY as of 1764288000 were 3185385 with a Short Ratio of 4.24, compared to 1761868800 on 3224022. Therefore, it implies a Short% of Shares Outstanding of 3185385 and a Short% of Float of 3.1.
Earnings Estimates
. The current market rating for Oncolytics Biotech, Inc (ONCY) reflects the collective analysis of 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.29 and -$0.41 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.34, with 5.0 analysts recommending between -$0.2 and -$0.53.
